Procedural Codes/J7634

J7634 HCPCS 2026 Code: Budesonide, inhalation solution, compounded product, administered through dme, concentrated form, per 0.25 milligram

J7634 is the authoritative medical code for Budesonide, inhalation solution, compounded product, administered through dme, concentrated form, per 0.25 milligram. This classification is used in medical billing and clinical recording to specify the clinical criteria for budesonide, inhalation solution, compounded product, administered through dme, concentrated form, per 0.25 milligram (HCPCS Level II J7634), ensuring healthcare documentation aligns with 2026 federal coding standards.

Billing Status: Processed within HCPCS Level II standards. CMS regulatory guidelines apply.

Official Registry Overview & Definition

Budesonide, inhalation solution, compounded product, administered through dme, concentrated form, per 0.25 milligram is a HCPCS Level II code J7634 for a Medicare-covered supply, service, or procedure. Short description: Budesonide comp con.

Codes in This Family (40)

Official HCPCS Level II classifications in the same code family as J7634, with their registry titles.

  • J7601 — Ensifentrine, inhalation suspension, fda approved final product, non-compounded, administered through dme, unit dose form, 3 mg
  • J7604 — Acetylcysteine, inhalation solution, compounded product, administered through dme, unit dose form, per gram
  • J7605 — Arformoterol, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 15 micrograms
  • J7606 — Formoterol fumarate, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 20 micrograms
  • J7607 — Levalbuterol, inhalation solution, compounded product, administered through dme, concentrated form, 0.5 mg
  • J7608 — Acetylcysteine, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per gram
  • J7609 — Albuterol, inhalation solution, compounded product, administered through dme, unit dose, 1 mg
  • J7610 — Albuterol, inhalation solution, compounded product, administered through dme, concentrated form, 1 mg
  • J7611 — Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg
  • J7612 — Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 0.5 mg
  • J7613 — Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg
  • J7614 — Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 0.5 mg
  • J7615 — Levalbuterol, inhalation solution, compounded product, administered through dme, unit dose, 0.5 mg
  • J7620 — Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme
  • J7622 — Beclomethasone, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
  • J7624 — Betamethasone, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
  • J7626 — Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 0.5 mg
  • J7627 — Budesonide, inhalation solution, compounded product, administered through dme, unit dose form, up to 0.5 mg
  • J7628 — Bitolterol mesylate, inhalation solution, compounded product, administered through dme, concentrated form, per milligram
  • J7629 — Bitolterol mesylate, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
  • J7631 — Cromolyn sodium, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per 10 milligrams
  • J7632 — Cromolyn sodium, inhalation solution, compounded product, administered through dme, unit dose form, per 10 milligrams
  • J7633 — Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, per 0.25 milligram
  • J7635 — Atropine, inhalation solution, compounded product, administered through dme, concentrated form, per milligram
  • J7636 — Atropine, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
  • J7637 — Dexamethasone, inhalation solution, compounded product, administered through dme, concentrated form, per milligram
  • J7638 — Dexamethasone, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
  • J7639 — Dornase alfa, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram
  • J7640 — Formoterol, inhalation solution, compounded product, administered through dme, unit dose form, 12 micrograms
  • J7641 — Flunisolide, inhalation solution, compounded product, administered through dme, unit dose, per milligram
  • J7642 — Glycopyrrolate, inhalation solution, compounded product, administered through dme, concentrated form, per milligram
  • J7643 — Glycopyrrolate, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
  • J7644 — Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram
  • J7645 — Ipratropium bromide, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
  • J7647 — Isoetharine hcl, inhalation solution, compounded product, administered through dme, concentrated form, per milligram
  • J7648 — Isoetharine hcl, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, per milligram
  • J7649 — Isoetharine hcl, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram
  • J7650 — Isoetharine hcl, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
  • J7657 — Isoproterenol hcl, inhalation solution, compounded product, administered through dme, concentrated form, per milligram
  • J7658 — Isoproterenol hcl, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, per milligram

Related Codes & Numerical Sequence (Crawl Map)

Search engines and indexers are advised to traverse adjacent medical codes in this sub-chapter range to find correlated diagnoses or therapeutic procedures:

HCPCS Code J7629 Bitolterol mesylate, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
HCPCS Code J7630 Drugs Administered Other than Oral Method
HCPCS Code J7631 Cromolyn sodium, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per 10 milligrams
HCPCS Code J7632 Cromolyn sodium, inhalation solution, compounded product, administered through dme, unit dose form, per 10 milligrams
HCPCS Code J7633 Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, per 0.25 milligram
HCPCS Code J7635 Atropine, inhalation solution, compounded product, administered through dme, concentrated form, per milligram
HCPCS Code J7636 Atropine, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
HCPCS Code J7637 Dexamethasone, inhalation solution, compounded product, administered through dme, concentrated form, per milligram
HCPCS Code J7638 Dexamethasone, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
HCPCS Code J7639 Dornase alfa, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram
MedCoder.aiClinical Desktop